Veterinary Biomarkers Market Size & Growth Forecast 2027–2036, By Segments (Animal Type, Product Type, Application, End-user, Disease Type), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Veterinary Biomarkers Market size was over USD 1.02 Billion in 2026 and is likely to grow at 10.49% CAGR between 2027 and 2036, reaching USD 2.77 Billion by 2036. The industry revenue for 2027 is calculated at USD 1.11 Billion.
Get more details on this report
Request Free Sample ReportVeterinary Biomarkers Market Intelligence Snapshot
Regional Market Dynamics
- North America led in 2026, supported by advanced veterinary infrastructure, precision diagnostics adoption, rising animal healthcare spending, and strong capabilities in veterinary research and laboratories.
- Asia Pacific is growing fastest as pet ownership, livestock health needs, veterinary infrastructure, diagnostic capabilities, and investment in modern animal healthcare continue expanding.
Segment Momentum
- Companion animals represented 62.98% of the market in 2026 and are the fastest-growing segment, driven by rising pet ownership, increased healthcare spending, and growing use of biomarker-based diagnostics for early disease detection and monitoring.
- Biomarker kits & reagents are the fastest-growing product segment, holding 59.52% of the market in 2026 due to their essential role in diagnostic testing, disease monitoring, and reliable biomarker detection across veterinary laboratories and clinics.
Market Expansion Drivers
- Rising pet ownership and spending accelerating veterinary biomarker diagnostics demand
- Advancements in diagnostic technologies improving early disease detection in animals
- Expansion of precision veterinary medicine driving biomarker-based health monitoring adoption
Leading Market Participants
- Top companies in the veterinary biomarkers market include Zoetis Inc. (United States), IDEXX Laboratories, Inc. (United States), bioMérieux SA (France), Merck KGaA (Germany), Virbac S.A. (France), Randox Laboratories Ltd. (United Kingdom), Bio-Rad Laboratories, Inc. (United States), Neogen Corporation (United States), Gentian Diagnostics ASA (Norway), Thermo Fisher Scientific Inc. (United States)
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 1.02 Billion
- 2027 Estimated Market Size: USD 1.11 Billion
- Projected Market Size: USD 2.77 Billion by 2036
- Growth Forecast: 10.49% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Companion Animals (Animal Type) | Biomarker Kits & Reagents (Product Type) | Clinical (Application) | Veterinary Clinics (End-user) | Inflammatory and Infectious Diseases (Disease Type)
- Emerging Opportunity Segment: Companion Animals (Animal Type) | Biomarker Kits & Reagents (Product Type) | Clinical (Application) | Veterinary Clinics (End-user) | Inflammatory and Infectious Diseases (Disease Type)
Market Growth Drivers and Industry Trends
Rising pet ownership and spending accelerating veterinary biomarker diagnostics demand
The increasing number of companion animals, combined with greater willingness among owners to invest in advanced healthcare, will drive the veterinary biomarkers market growth. Pet owners are seeking earlier diagnosis and more proactive disease management to improve the quality of life and longevity of their animals. Biomarker-based diagnostic testing enables veterinarians to identify health conditions at earlier stages, supporting more informed clinical decisions and personalized treatment approaches across a wide range of companion animal diseases.
Advancements in diagnostic technologies improving early disease detection in animals
Rapid progress in veterinary diagnostic technologies is strengthening the role of biomarkers in modern animal healthcare, allowing the veterinary biomarkers market to expand through more accurate and timely disease identification. Improvements in molecular diagnostics, immunoassays, and laboratory automation are enhancing the sensitivity and reliability of biomarker testing across infectious diseases, metabolic disorders, and chronic health conditions. Faster diagnostic workflows also enable veterinary professionals to initiate appropriate treatment strategies with greater confidence while improving overall clinical efficiency.
Expansion of precision veterinary medicine driving biomarker-based health monitoring adoption
The growing emphasis on individualized animal healthcare is encouraging broader use of biomarker-guided diagnostics, which will boost the veterinary biomarkers market demand. Precision veterinary medicine relies on biological indicators to evaluate disease progression, treatment response, and long-term health status, enabling more tailored therapeutic decisions for companion and production animals. The integration of biomarker information into routine veterinary practice supports continuous health monitoring while helping clinicians optimize preventive care and disease management strategies.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising pet ownership and spending accelerating veterinary biomarker diagnostics demand | 2% | Moderate | North America, Europe | High | Near Term |
| Advancements in diagnostic technologies improving early disease detection in animals | 1.8% | Moderate | North America, Asia Pacific | High | Near Term |
| Expansion of precision veterinary medicine driving biomarker-based health monitoring adoption | 1.5% | Low | North America, Europe | Medium | Mid Term |
Explore Growth Opportunities
Request Free Sample ReportRegional Demand Dynamics
North America (Largest Region)
North America led the veterinary biomarkers market in 2026, supported by advanced veterinary healthcare infrastructure, increasing adoption of precision diagnostics, and strong demand for early detection of animal diseases. The region's developed veterinary care ecosystem enables greater use of biomarker-based testing across companion animals and livestock applications. Rising expenditure on animal healthcare and growing awareness of preventive veterinary medicine are also encouraging the adoption of diagnostic technologies that can support disease identification, treatment selection, and health monitoring. In addition, advancements in veterinary research and laboratory capabilities are creating a favorable environment for the development and commercialization of biomarker-based diagnostic solutions.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is anticipated to experience the fastest growth, driven by expanding animal healthcare needs, rising pet ownership, and increasing attention to livestock health and disease management. Improvements in veterinary infrastructure and diagnostic capabilities are making advanced testing more accessible across developing markets. Growing awareness of animal disease prevention and the economic importance of maintaining livestock health are also supporting demand for early and accurate diagnostic approaches. Moreover, increasing investment in veterinary healthcare, greater adoption of modern diagnostic technologies, and the expansion of organized animal care services are creating favorable conditions for wider use of veterinary biomarkers across the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants/Startups i Scale Low Medium High | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
United States 🇺🇸
Precision Animal DiagnosticsThe U.S. veterinary biomarkers market is expanding through increasing use of advanced diagnostic tools for companion animals and livestock. Companies are developing biomarker-based tests that improve disease detection, treatment monitoring, and personalized veterinary care across clinical settings.
Germany 🇩🇪
Clinical Research AlignmentGermany is strengthening veterinary biomarker adoption through active research collaborations and high diagnostic quality standards. Manufacturers are focusing on validated biomarkers that support accurate disease identification and improve decision-making in veterinary practice.
Japan 🇯🇵
Companion Animal CareJapan is increasing the use of veterinary biomarkers as demand grows for sophisticated healthcare solutions for companion animals. Diagnostic developers are introducing sensitive testing platforms that assist early disease detection and long-term health management in veterinary clinics.
South Korea 🇰🇷
Diagnostic Technology ExpansionSouth Korea is enhancing veterinary biomarker applications through continued investment in laboratory diagnostics and animal healthcare innovation. Companies are expanding testing capabilities that support faster diagnosis and more targeted treatment approaches for veterinary professionals.
France 🇫🇷
Livestock Health MonitoringFrance is utilizing veterinary biomarkers to improve disease surveillance and herd health management alongside companion animal diagnostics. Market participants are emphasizing reliable biomarker assays that strengthen preventive veterinary care and production efficiency.
Italy 🇮🇹
Veterinary Laboratory ModernizationItaly is modernizing veterinary diagnostic services through wider adoption of biomarker-based testing in animal health laboratories. Suppliers are introducing practical diagnostic solutions that support earlier clinical intervention and more informed treatment decisions across veterinary care.
Segment Leadership and Growth Trends
Veterinary Biomarkers Market Share (%), by Animal Type, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportAnimal Type Segment Analysis: Companion Animals (Largest & Fastest-Growing Segment)
The veterinary biomarkers market was led by the companion animals segment, which held the largest share of 62.98% in 2026, while also emerging as the fastest-growing segment. The segment's strong position is supported by increasing pet ownership, growing expenditure on animal healthcare, and heightened awareness of preventive veterinary medicine. Biomarkers are increasingly incorporated into the diagnosis and monitoring of chronic diseases, infectious conditions, and age-related disorders in companion animals, enabling earlier detection and more personalized treatment strategies. Continuous advancements in veterinary diagnostics, expanding availability of specialized veterinary services, and greater emphasis on improving animal health outcomes are further accelerating the adoption of biomarker-based testing for companion animals.
Product Type Segment Analysis: Biomarker Kits & Reagents (Largest & Fastest-Growing Segment)
Holding the largest share of the veterinary biomarkers market, the biomarker kits & reagents segment accounted for 59.52% in 2026 and also represented the fastest-growing segment. The widespread use of kits and reagents stems from their essential role in routine diagnostic testing, research activities, and disease monitoring across veterinary laboratories and clinical settings. Their compatibility with diverse testing platforms, ease of use, and ability to support reliable biomarker detection make them indispensable components of veterinary diagnostic workflows. Ongoing innovation in assay development, increasing demand for rapid and accurate diagnostics, and expanding applications in animal disease management continue to reinforce the segment's leadership and sustained growth.
Application Segment Analysis: Clinical (Largest & Fastest-Growing Segment)
The clinical application segment dominated the veterinary biomarkers market, holding the largest share of 74.98% in 2026, while also recording the fastest growth. Clinical applications remain the primary area of biomarker utilization because they support disease diagnosis, treatment monitoring, prognosis assessment, and preventive health screening across a wide range of animal species. Veterinary professionals are increasingly relying on biomarker-based diagnostics to improve clinical decision-making and deliver timely therapeutic interventions. Rising demand for precision veterinary care, expanding diagnostic capabilities, and continued integration of advanced laboratory technologies are expected to further strengthen the clinical segment's leading position.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Animal Type | Companion Animals, Livestock Animals | Companion Animals | Companion Animals |
| Product Type | Biomarker Readers, Biomarker Kits & Reagents | Biomarker Kits & Reagents | Biomarker Kits & Reagents |
| Application | Clinical, Research | Clinical | Clinical |
| End-user | Veterinary Hospitals, Veterinary Clinics, Research Institutes, Reference Laboratories | Veterinary Clinics | Veterinary Clinics |
| Disease Type | Inflammatory and Infectious Diseases, Cardiovascular Diseases, Renal Diseases, Cancer, Others | Inflammatory and Infectious Diseases | Inflammatory and Infectious Diseases |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Competitive Landscape and Market Positioning
Top players in the veterinary biomarkers market:
- Zoetis, Inc. (United States)
- IDEXX Laboratories, Inc. (United States)
- bioMérieux SA (France)
- Merck KGaA (Germany)
- Virbac S.A. (France)
- Randox Laboratories Ltd. (United Kingdom)
- Bio-Rad Laboratories, Inc. (United States)
- Neogen Corporation (United States)
- Gentian Diagnostics ASA (Norway)
- Thermo Fisher Scientific, Inc. (United States)
Innovation within veterinary diagnostics is steadily shifting competition toward the development of biomarkers capable of supporting earlier disease detection, more precise treatment decisions, and continuous health monitoring across multiple animal species. Rather than competing solely through assay availability, market participants are differentiating through scientific validation, diagnostic accuracy, and compatibility with increasingly integrated laboratory and point-of-care testing workflows. Growing interest in personalized veterinary care is further encouraging investment in multiplex testing approaches and data-driven diagnostic platforms that enhance clinical confidence while expanding the practical application of biomarker-based decision making.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Zoetis Inc. (United States) | |||||||
| IDEXX Laboratories Inc. (United States) | |||||||
| bioMérieux SA (France) | |||||||
| Merck KGaA (Germany) | |||||||
| Virbac S.A. (France) | |||||||
| Randox Laboratories Ltd. (United Kingdom) | |||||||
| Bio-Rad Laboratories Inc. (United States) | |||||||
| Neogen Corporation (United States) | |||||||
| Gentian Diagnostics ASA (Norway) | |||||||
| Thermo Fisher Scientific Inc. (United States) |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Virbac | Jan-25 | Virbac partnered with Emmyon to launch URSOLYX Soft Chews utilizing ursolic acid. This commercial introduction targets muscle biomarker enhancement and functional performance optimization for aging and active canine populations. |
| Boehringer Ingelheim International GmbH | Sep-24 | Boehringer Ingelheim International GmbH completed the acquisition of Saiba Animal Health AG to integrate its advanced vaccine development platform, specifically designed to strengthen the company competitive portfolio in veterinary therapeutics and oncology. |
| Dechra Pharmaceuticals PLC | Jul-24 | Dechra Pharmaceuticals PLC acquired Invetx to incorporate its proprietary therapeutic pipeline and expand operational capabilities within the animal health sector. |
| Zoetis Inc. | Oct-21 | Zoetis Inc. executed a facility expansion at its manufacturing and development site located in Tullamore, Ireland. The strategic capital investment was designed to scale production capacity for veterinary monoclonal antibodies to support growing commercial demand. |
| Bionote | Aug-21 | Bionote expanded its Vcheck diagnostic portfolio with the commercial release of the Vcheck Canine TnI quantitative in vitro test. The solution enables precise measurement of cardiac Troponin I levels in canine serum to support advanced veterinary cardiac health monitoring. |
| Roslin Technologies | Jun-20 | Roslin Technologies formed a joint venture by launching Vetsina Animal Diagnostics alongside Destina Genomics. The initiative focuses on leveraging microRNA biomarkers to accelerate diagnostic testing speeds, improve remote sample utilization, and enhance disease detection capabilities in animal care. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Veterinary Biomarkers Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Biomarker Type | Protein Biomarkers, Genetic Biomarkers, Metabolite Biomarkers, Hormonal Biomarkers, Cellular Biomarkers |
| Sample Type | Blood & Serum, Urine, Tissue, Saliva, Other Biological Samples |
| Testing Method | Immunoassay-Based Testing, Molecular Testing, Chromatography-Based Testing, Mass Spectrometry, Other Analytical Methods |
Veterinary Biomarkers Market — Custom TOC
| Custom Chapter | Chapter Details |
|---|---|
| Companion Animal Precision Medicine Adoption |
|
| Veterinary Biomarker Commercialization Pathways |
|
| Pet Health Insurance Impact on Biomarker Demand |
|
Need a different cut of the data?
Request Custom ResearchWhat is the market valuation of veterinary biomarkers?
How is the veterinary biomarkers industry size expected to evolve during the forecast period?
How is precision veterinary medicine influencing adoption of biomarker-based diagnostics?
Why are advances in diagnostic technologies accelerating the veterinary biomarkers market?
Why do companion animals account for the largest share of the veterinary biomarkers market?
Which product type is expanding the fastest in the veterinary biomarkers market?
Why does North America lead the veterinary biomarkers market?
What is driving rapid growth in Asia Pacific's veterinary biomarkers market?
Which companies dominate the veterinary biomarkers landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Intelligence
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization